Trial intelligence / Profile preview

Levocetirizine for nasal obstruction in perennial allergic rhinitis

2006-005608-15Phase 4Active

Sponsor
Institut für Atemwegsforschung
Start
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in perennial rhinitis comparing Levocetirizine with Placebo (2 arms). Primary endpoint: Average morning nasal obstruction score. Started Nov 2006; status: active.

02

Drugs

levocetirizine
03

Conditions

perennial rhinitis

Beyond the preview

Go deeper on 2006-005608-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005608-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call